Evidence map›Paper›PMID 24361609›Full record

ArticleBiochimica et biophysica acta2014

Platelets do not express the oxidized or reduced forms of tissue factor.

Beth A Bouchard, Matthew T Gissel, Matthew F Whelihan, Kenneth G Mann, Saulius Butenas

Abstract read
In one paragraph

Article in Biochimica et biophysica acta, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Beth A BouchardDepartment of Biochemistry, University of Vermont College of Medicine, Burlington, VT, USA.
Matthew T GisselDepartment of Biochemistry, University of Vermont College of Medicine, Burlington, VT, USA.
Matthew F WhelihanDepartment of Biochemistry, University of Vermont College of Medicine, Burlington, VT, USA.
Kenneth G MannDepartment of Biochemistry, University of Vermont College of Medicine, Burlington, VT, USA.
Saulius ButenasDepartment of Biochemistry, University of Vermont College of Medicine, Burlington, VT, USA. Electronic address: sbutenas@uvm.edu.
University of Vermont · US

Funding

VENOUS THROMBOEMBOLISM: GENES, RISK, MANAGEMENTP01HL046703 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI TRACY, PAULA BABIARZ · 1991 to 2011
$19.8M
Research Training in Hematology at UNC Chapel HillT32HL007149 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Nigel S. Key · 1985 to 2026
$8.6M
Membrane Receptors Regulating Megakaryocyte Endocytosis of Factor V from PlasmaK02HL091111 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BOUCHARD, BETH · 2008 to 2012
$392k
NHLBI NIH HHS K02 HL091111NHLBI NIH HHS K02 HL91111NHLBI NIH HHS P01 HL046703NHLBI NIH HHS P01 HL46703NHLBI NIH HHS T32 HL007149
6 · The paper itself

Abstract

backgroundExpression of tissue factor (TF) antigen and activity in platelets is controversial and dependent upon the laboratory and reagents used. Two forms of TF were described: an oxidized functional form and a reduced nonfunctional form that is converted to the active form through the formation of an allosteric disulfide. This study tests the hypothesis that the discrepancies regarding platelet TF expression are due to differential expression of the two forms.

methodsSpecific reagents that recognize both oxidized and reduced TF were used in flow cytometry of unactivated and activated platelets and western blotting of whole platelet lysates. TF-dependent activity measurements were used to confirm the results.

resultsWestern blotting analyses of placental TF demonstrated that, in contrast to anti-TF#5, which is directed against the oxidized form of TF, a sheep anti-human TF polyclonal antibody recognizes both the reduced and oxidized forms. Flow cytometric analyses demonstrated that the sheep antibody did not react with the surface of unactivated platelets or platelets activated with thrombin receptor agonist peptide, PAR-1. This observation was confirmed using biotinylated active site-blocked factor (F)VIIa: no binding was observed. Likewise, neither form of TF was detected by western blotting of whole platelet lysates with sheep anti-hTF. Consistent with these observations, no FXa or FIXa generation by FVIIa was detected at the surface of these platelets. Similarly, no TF-related activity was observed in whole blood using thromboelastography. CONCLUSION AND SIGNIFICANCE: Platelets from healthy donors do not express either oxidized (functional) or reduced (nonfunctional) forms of TF.

Indexed as

AnimalsAntibodiesBlood PlateletsBlotting, WesternFlow CytometryHumansOxidation-ReductionSheepThromboplastinAntibodiesThromboplastin312.5mM Tris, pH6.8, 10% sodium dodecyl sulfate, 50% glycerol, 0.05% bromophenol blue5× SPB80% phosphatidylcholine/20% phosphatidylserine containing vesiclesapparent molecular weightArg-Gly-Asp-Sercorn trypsin inhibitorCTID-Phe-Pro-Arg-CH(2)ClFfactorFactor VIIaFlow cytometryFPRckHemostasishorseradish peroxidaseHRPhTFhuman TFkDakilodaltonlipopolysaccharideLPSMr(app)PARPCPSPEphycoerythrinPlateletplatelet-rich plasmaprotease activated receptorPRPrecombinant FVIIarFVIIaRGDSSDS-PAGEsodium dodecyl sulfate-polyacrylamide gel electrophoresisTATTEGTFthrombin-antithrombinthromboelastographytissue factorTissue factor

Identifiers

PMID24361609
PMCPMC3920906
OpenAlexW2064462266

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.